K Pharma (TSE:4896) FCF Margin %: 0.00% (As of Dec. 2025)


TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円704.00
! 1 Warning Sign
View Full Analysis

What is K Pharma FCF Margin %?

K Pharma TSE:4896 +9.15% 11 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, K Pharma ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. K Pharma's Free Cash Flow for the three months ended in Dec. 2025 was 円0.00 Mil. K Pharma's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, K Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, K Pharma's current FCF Yield % is -11.35%.

The historical rank and industry rank for K Pharma's FCF Margin % or its related term are showing as below:


During the past 5 years, the highest FCF Margin % of K Pharma was 44.46%. The lowest was 44.46%. And the median was 44.46%.

TSE:4896's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

K Pharma FCF Margin % Related Terms

K Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for K Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma FCF Margin % Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 44.46 0.00 0.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4896 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, K Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

K Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, K Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where K Pharma's FCF Margin % falls into.


TSE:4896
11GF Score
K Pharma Inc TSE:4896
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

K Pharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-929.191/0
= %

K Pharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
K Pharma (TSE:4896) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on K Pharma and its competitors. Over the past decade, K Pharma's FCF Margin % has ranged from 44.46 to 44.46. According to the industry distribution chart, K Pharma ranks #999999 out of 959 companies in the Biotechnology industry.
Is K Pharma's FCF Margin % too high?
K Pharma's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 44.46 to a high of 44.46. Based on the distribution chart, K Pharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, K Pharma ranks #999999 out of 959 companies for FCF Margin %. This places K Pharma in the lower half of its industry. Historically, K Pharma's own FCF Margin % has ranged from 44.46 to 44.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on K Pharma and its competitors. K Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For K Pharma (TSE:4896), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円704.00
Price